Myeloma consensus guidelines

Home | Science and research | Myeloma consensus guidelines
People of different races hold hands in a unity circle of support

Standardizing myeloma diagnosis, treatment, and management across Canada

Recognizing the need for medical consensus on the diagnosis, treatment, and management of myeloma in Canada across all provinces, Myeloma Canada led the development of the first Canadian evidence-based treatment guidelines in collaboration with a team of Canadian myeloma experts.

Managed and financed by Myeloma Canada, the Canadian Evidence-based Myeloma Canada Consensus Guidelines is a series of peer-reviewed publications that are aimed to improve, standardize, and educate physicians on the management of myeloma in Canada.

Asian male doctor shows patient something

What is the purpose of creating these guidelines?

As there were no unified Canadian national guidelines for the diagnosis and treatment of multiple myeloma, there was a need for evidence-based national recommendations.

Although some provinces do have their own guidelines, the Canadian national guidelines take provincial variations in access and funding into consideration. The overarching goal is to provide Canadian clinicians with concise diagnostic recommendations upon which therapeutic decisions can be made. The focus is on relevance, applicability, and the use of the various tests available in routine Canadian practice.

The guidelines

"Photo of article ""Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium"" published in Clinical Lymphoma, Myeloma & Leukemia"

Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders

Published February 2020 in Clinical Lymphoma, Myeloma & Leukemia
Photo of article "Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium" published in Clinical Lymphoma, Myeloma & Leukemia

Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care

Published January 2022 in Clinical Lymphoma, Myeloma & Leukemia

Photo of article, "First line treatment of newly diagnosed transplant ineligible multiple myeloma" published in Clinical Lymphoma, Myeloma & Leukemia

First line treatment of newly diagnosed transplant ineligible multiple myeloma

Published February 2023 in Clinical Lymphoma, Myeloma & Leukemia